These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21638977)

  • 21. The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. III. Neural and other impairments.
    Schreuder PA
    Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):170-81. PubMed ID: 9728449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knowledge and management of disabling conditions in South Asian histories: implications for leprosy futures.
    Miles M
    Indian J Lepr; 2003; 75(2):153-67. PubMed ID: 15255402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A research strategy to develop new tools to prevent leprosy, improve patient care and reduce the consequences of leprosy. Five year leprosy research strategy approved by ILEP Board October 2011.
    Smith WC;
    Lepr Rev; 2012 Mar; 83(1):6-15. PubMed ID: 22655465
    [No Abstract]   [Full Text] [Related]  

  • 24. Sustainable leprosy related disability care within integrated general health services: findings from Salem District, India.
    Madhavan K; Vijayakumaran P; Ramachandran L; Manickam C; Rajmohan R; Mathew J; Krishnamurthy P
    Lepr Rev; 2007 Dec; 78(4):353-61. PubMed ID: 18309709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of nerve damage in leprosy patients treated with MDT.
    Solomon S; Kurian N; Ramadas P; Rao PS
    Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):451-6. PubMed ID: 10347565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guidelines for implementing a disability prevention programme in the field. National Leprosy Elimination Programme (NLEP).
    Srinivasan H
    Indian J Lepr; 1999; 71(4):539-612. PubMed ID: 10804982
    [No Abstract]   [Full Text] [Related]  

  • 27. Impairment and disability in leprosy: in search of the missing link.
    van Brakel WH; Anderson AM
    Indian J Lepr; 1997; 69(4):361-76. PubMed ID: 9474512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Commitment to reducing disability: the Brazilian experience.
    Oliveira ML; Grossi MA; Oliveira CF; Sena SA; Daxbacher E; Penna GO
    Lepr Rev; 2010 Dec; 81(4):342-5. PubMed ID: 21313981
    [No Abstract]   [Full Text] [Related]  

  • 29. Bangkok Workshop on Leprosy Research. Research needs related to disabilities and rehabilitation.
    Smith WC; van Brakel WH
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S52-4; discussion S54-5. PubMed ID: 9030125
    [No Abstract]   [Full Text] [Related]  

  • 30. Nerve damage in leprosy and its management.
    Wilder-Smith EP; Van Brakel WH
    Nat Clin Pract Neurol; 2008 Dec; 4(12):656-63. PubMed ID: 19002133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The leprosy granuloma in nerve: summary of recent work.
    Ridley MJ
    Indian J Lepr; 1996; 68(1):93-4. PubMed ID: 8727119
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessing socio-economic factors in relation to stigmatization, impairment status, and selection for socio-economic rehabilitation: a 1-year cohort of new leprosy cases in north Bangladesh.
    Withington SG; Joha S; Baird D; Brink M; Brink J
    Lepr Rev; 2003 Jun; 74(2):120-32. PubMed ID: 12862253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Final report about Stage II Collaboration Project on Leprosy Rehabilitation.
    Zhang G; Yan L; Jiang J; Wei X; Wu Y; Li W; Chen X; Samson PD; Watson JM; Piefer A
    Chin Med Sci J; 2000 Sep; 15(3):187-90. PubMed ID: 12903783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrating community-based rehabilitation and leprosy rehabilitation services into an inclusive development approach.
    Finkenflügel H; Rule S
    Lepr Rev; 2008 Mar; 79(1):83-91. PubMed ID: 18540239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Not by chemotherapy alone.
    Srinivasan H
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):404-11. PubMed ID: 7963914
    [No Abstract]   [Full Text] [Related]  

  • 36. Pattern of leprosy disabilities in Gorakhpur (Uttar Pradesh).
    Girdhar M; Arora SK; Mohan L; Mukhija RD
    Indian J Lepr; 1989 Oct; 61(4):503-13. PubMed ID: 2533603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 26th Kellersberger Memorial Lecture. Lessons from leprosy rehabilitation for general rehabilitation.
    Brandsma JW
    Ethiop Med J; 2003 Jan; 41(1):77-87. PubMed ID: 12765003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline.
    Van Brakel WH; Nicholls PG; Das L; Barkataki P; Maddali P; Lockwood DN; Wilder-Smith E
    Lepr Rev; 2005 Dec; 76(4):277-95. PubMed ID: 16411508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Approaches and tools for measuring disability in low and middle-income countries.
    Van Brakel WH; Officer A
    Lepr Rev; 2008 Mar; 79(1):50-64. PubMed ID: 18540237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global trends in disability rehabilitation and their implications for leprosy programmes.
    Thomas M; Thomas MJ
    Lepr Rev; 2008 Mar; 79(1):10-6. PubMed ID: 18540233
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.